Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

Ítems similars

• Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission?
  per: Araki, Daisuke, et al.
  Publicat: (2016)
• Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia
  per: Othus, Megan, et al.
  Publicat: (2016)
• Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
  per: Walter, Roland B., et al.
  Publicat: (2011)
• Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
  per: Bar, Merav, et al.
  Publicat: (2014)
• Impact of Residual Normal Metaphases in Core Binding Factor Acute Myeloid Leukemia
  per: Medeiros, Bruno C., et al.
  Publicat: (2011)